Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.64M P/E - EPS this Y 98.00% Ern Qtrly Grth -
Income -17.91M Forward P/E -1.66 EPS next Y 70.90% 50D Avg Chg -32.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -76.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -94.00%
Recommedations 2.00 Quick Ratio 0.96 Shares Outstanding 17.27M 52W Low Chg 4.00%
Insider Own 0.04% ROA -207.95% Shares Float 17.26M Beta 0.47
Inst Own 11.46% ROE -1,048.70% Shares Shorted/Prior 0.90M/175.77K Price 2.02
Gross Margin - Profit Margin - Avg. Volume 274,620 Target Price -
Oper. Margin - Earnings Date - Volume 65,494 Change -3.81%
About TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer. The company's lead therapeutic candidate comprises TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in various cancers comprising breast, pancreatic, ovarian, colon cancer, glioblastomas, and others. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 and two indication agnostic programs; TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. has strategic collaboration agreement with The University of Texas M. D. Anderson Cancer Center. The company was incorporated in 2016 and is based in Boston, Massachusetts.

TransCode Therapeutics, Inc. News
11/29/24 TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
11/28/24 Transcode Therapeutics issues 21.2M shares at 37.7c in private placement
11/27/24 TransCode Therapeutics, Inc. Announces $8 Million Private Placement
11/26/24 Transcode Therapeutics announces 1-for-33 reverse stock split
11/12/24 TransCode Therapeutics Open Letter to Shareholders
11/05/24 TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
10/23/24 TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
10/10/24 TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
09/17/24 TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
09/10/24 TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
09/05/24 TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
08/15/24 TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
07/24/24 TransCode Therapeutics, Inc. Announces Closing of Public Offering
07/22/24 TransCode Therapeutics, Inc. Announces Pricing of Public Offering
07/22/24 TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
06/10/24 Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
05/29/24 TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
04/15/24 TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
04/03/24 TransCode Therapeutics Reports 2023 Results; Provides Business Update
03/28/24 TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
RNAZ Chatroom

User Image gscdefense Posted - 7 hours ago

$RNAZ damn is the ask really $8.48

User Image dogood Posted - 12 hours ago

$RNAZ my average is $190

User Image rock_it_stocks Posted - 12 hours ago

$RNAZ Tom got his reverse split, approval for disenfranchising shareholders and a cash injection to meet minimum equity, bolster working capital and corporate initiatives, but an $8 million investment on Monday is worth less than $5 million within 5 days. What have you done for us lately, Tom? How much could a few blood tests cost, and, honestly, how long could it possibly take to get the results? Your previous "studies" seemed to show that this data is ascertainable within a few days. You've got LabCorp on mothereffing speed dial!!! We don't need to know about regression. We don't need to know about delivery to targets. What are the effing miR-10b levels, Tom? Are you and your "doctors" effing morons???

User Image Hass19 Posted - 14 hours ago

$RNAZ Mofo crooks 🤥

User Image Vedran1 Posted - 14 hours ago

$RNAZ What we need the most here is a large inflow of new enthusiastic investors instead of burned down to ground ones - like us.

User Image Itinerant Posted - 15 hours ago

$RNAZ Do not be misled by the reported market cap of $6 or $8 million. That is complete nonsense. The massive warrant over hang means that the real market cap is about $25 million. That is actually a reasonable number for the company's present state of development. Of course, the market cap could be $100 million if the company were to actually disclose efficacy, but they probably feel that they cannot yet do that without litigation risk. That is a question for the securities lawyers.

User Image Hovius Posted - 15 hours ago

$RNAZ Itinerant got mad and blocked me.. She had enough of my negativity.. 😝

User Image Itinerant Posted - 16 hours ago

$RNAZ Has Tom Fitzgerald changed his email address? I tried and it did not go through. Does anyone know something about this?

User Image Hovius Posted - 17 hours ago

$RNAZ This has to be dilution, right?

User Image phantomtrader75 Posted - 17 hours ago

$RNAZ UNFATHOMABLE

User Image septrading Posted - 17 hours ago

$RNAZ Tommy boy must be on a hell of a bender.

User Image septrading Posted - 17 hours ago

$RNAZ now their website is down? yikes

User Image Hovius Posted - 20 hours ago

$RNAZ lol.. luckily, I only went back in with $1000. 😝

User Image phantomtrader75 Posted - 1 day ago

$RNAZ where is everyone? Did the watchers also get split by 33?

User Image phantomtrader75 Posted - 1 day ago

$RNAZ INSANITY TO SHORT THIS FLOAT

User Image trading_momentum Posted - 2 days ago

$APVO and $RNAZ went cil in fidelity

User Image Hass19 Posted - 2 days ago

$RNAZ 🚀

User Image PenkeTrading Posted - 2 days ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Transcode Therapeutics Inc. Is that bullish or bearish? $RNAZ #Transcode #RsiOverbought #NASDAQ

User Image Stocksrunner Posted - 2 days ago

Today’s winners! These stocks started down but turned it around, closing strong! $GWAV $RENB $MTEX $RNAZ $AEON Huge bounce-back moves! Stay sharp, traders! These stocks know how to fight back!

User Image TheyCallMeTheCleaner Posted - 2 days ago

$RNAZ Time to pay up shorty!

User Image Itinerant Posted - 2 days ago

$RNAZ I see the remarks that we will not be receiving any substantial information until next May. I respect that opinion, but I am hopeful that it is simply not correct. My reasoning is this. First and most important, the cycle time of treatment in this technology is extraordinary. Never before (I believe) have we seen a tech where you get a treatment and within a couple/three weeks the doctors can directly observe the treatment result. This fact means that the progression of clinical trials should be rapid and dramatic. Second, the observable treatment result is a clear and obvious therapeutic consequence of enormous significance. It is the direct observance of the elimination of the metastases! Thirdly, the company will need to raise further funds, obviously. This will necessitate the release of efficacy information even though the data will be classified as tentative or preliminary or some other cautionary verbiage. Nevertheless, we will all know that it is real. JMO

User Image Jetman1 Posted - 2 days ago

$RNAZ Buy it now. It looks like this stock will get to $15 soon.

User Image Bigmoney4me Posted - 2 days ago

$CYCN $RNAZ $AMGN guys look at $APTO 2 dollah pt ! got $$ first then this news : SAN DIEGO and TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced that the National Cancer Institute (NCI), part of the National Institutes of Health, and Aptose Biosciences Inc. have entered into a Cooperative Research and Development Agreement (“CRADA”). Under the CRADA, the NCI and Aptose will collaborate on the clinical development of Aptose’s proprietary lead clinical-stage compound tuspetinib (TUS), an inhibitor of key signaling kinases involved in myeloid malignancies, in the NCI Cancer Therapy Evaluation Program (CTEP) sponsored myeloMATCH trials employing combinations of targeted therapy for the treatment of molecularly defined acute myeloid leukemia (AML) and myelodysplastic syndr

User Image Trissy08 Posted - 2 days ago

$RNAZ ok. Now the r/s has happened. What’s next for this one? What do we know/see/think will happen over the coming weeks/months?

User Image BobBuran Posted - 2 days ago

Wednesday This is the SECOND of TWO posts showing a total of about 50 of my buy stop orders (LE for long entry) above the market for today. PLEASE IGNORE ALL ORDERS MARKED SX SE or LX. Already bot past ten minutes: $POWL $XCUR $RNAZ #stocks

User Image BobBuran Posted - 2 days ago

Wednesday This is the first of TWO posts showing a total of about 50 of my buy stop orders (LE for long entry) above the market for today. PLEASE IGNORE ALL ORDERS MARKED SX SE or LX. Already bot past ten minutes: $POWL $XCUR $RNAZ #stocks

User Image Vedran1 Posted - 2 days ago

$RNAZ What is the meaning of "acredited investors" mentioned in the private placement? Copilot: "An accredited investor is an individual or entity that is allowed to invest in securities that are not registered with financial authorities, such as the Securities and Exchange Commission (SEC) in the United States. These investments often include private equity, hedge funds, venture capital, and other high-risk, high-reward opportunities."

User Image tradingcalendar Posted - 2 days ago

$APVO 1-for-37 reverse stock split Share float reduced to 500K from 18.5M $RNAZ 1-for-33 reverse stock split Share float reduced to 523K from 17.3M $ANET 4-for-1 stock split Shares outstanding increases to 1.26B from 315M

User Image Drizzyman Posted - 2 days ago

$RNAZ Release the damn data already on regression...

User Image Hovius Posted - 2 days ago

$RNAZ I wonder if shorts are about to inappropriately touch this stock?

Analyst Ratings
HC Wainwright & Co. Buy Sep 6, 24
HC Wainwright & Co. Buy Aug 15, 24
HC Wainwright & Co. Buy May 29, 24
HC Wainwright & Co. Buy May 16, 24
HC Wainwright & Co. Buy Apr 16, 24
HC Wainwright & Co. Buy Apr 3, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Fitzgerald Thomas A Chief Financial Offi.. Chief Financial Officer Sep 28 Buy 0.51 49,350 25,168 56,318 10/02/23
Dudley Robert Michael Chief Executive Offi.. Chief Executive Officer Sep 28 Buy 0.51 98,000 49,980 180,262 10/02/23
Dudley Robert Michael Chief Executive Offi.. Chief Executive Officer Jun 20 Buy 2.6 18,607 48,378 82,262 06/22/23
Dudley Robert Michael Chief Executive Offi.. Chief Executive Officer Jun 09 Buy 2.76 19,000 52,440 912,114 06/13/23
Dudley Robert Michael Chief Executive Offi.. Chief Executive Officer Sep 14 Buy 1.15 20,000 23,000 893,114 09/16/22